Verónica Galván

8.9k total citations · 2 hit papers
93 papers, 6.7k citations indexed

About

Verónica Galván is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Verónica Galván has authored 93 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Physiology, 37 papers in Molecular Biology and 23 papers in Neurology. Recurrent topics in Verónica Galván's work include Alzheimer's disease research and treatments (43 papers), Genetics, Aging, and Longevity in Model Organisms (13 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Verónica Galván is often cited by papers focused on Alzheimer's disease research and treatments (43 papers), Genetics, Aging, and Longevity in Model Organisms (13 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Verónica Galván collaborates with scholars based in United States, Hungary and Argentina. Verónica Galván's co-authors include Dale E. Bredesen, Olivia Gorostiza, Bernard Roizman, Zoltán Ungvári, Arlan Richardson, Anna Csiszár, Stefano Tarantini, Matthew J. Hart, Natalia Podlutskaya and Randy Strong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Verónica Galván

92 papers receiving 6.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

2010 807 citations Patricia Spilman, Natalia Podlutskaya et al. PLoS ONE profile →
Mechanisms of Vascular Aging

2018 613 citations Zoltán Ungvári, Stefano Tarantini et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Verónica Galván	2.9k	2.6k	1.1k	1.1k	1.1k	93	6.7k
Tao Lu	2.1k 0.7×	3.4k 1.3×	1.2k 1.0×	928 0.8×	819 0.7×	111	7.3k
Aiwu Cheng	2.6k 0.9×	3.5k 1.3×	668 0.6×	1.3k 1.1×	1.3k 1.2×	54	7.8k
Xia Liu	2.3k 0.8×	4.1k 1.6×	464 0.4×	2.1k 1.8×	963 0.9×	195	8.8k
Marcello D’Amelio	1.4k 0.5×	1.9k 0.7×	874 0.8×	1.2k 1.1×	737 0.7×	90	4.7k
Li Gan	3.9k 1.4×	4.5k 1.7×	940 0.8×	2.2k 1.9×	2.5k 2.2×	165	10.9k
Gennaro Schettini	1.8k 0.6×	3.4k 1.3×	799 0.7×	1.6k 1.4×	1.0k 0.9×	198	8.2k
Jonathan D. Geiger	2.2k 0.8×	3.1k 1.2×	660 0.6×	2.1k 1.9×	1.2k 1.1×	163	8.2k
Alberto Rábano	2.7k 0.9×	3.0k 1.1×	398 0.3×	1.8k 1.6×	1.9k 1.7×	148	7.7k
David Blum	2.5k 0.9×	3.0k 1.1×	411 0.4×	2.7k 2.4×	1.6k 1.4×	194	8.6k
Jorge Busciglio	4.3k 1.5×	3.5k 1.4×	332 0.3×	1.7k 1.5×	1.1k 1.0×	65	7.9k

Countries citing papers authored by Verónica Galván

Since Specialization

Citations

This map shows the geographic impact of Verónica Galván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Galván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Galván more than expected).

Fields of papers citing papers by Verónica Galván

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Galván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Galván. The network helps show where Verónica Galván may publish in the future.

Co-authorship network of co-authors of Verónica Galván

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Galván. A scholar is included among the top collaborators of Verónica Galván based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Galván. Verónica Galván is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Rong, et al.. (2023). Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice. GeroScience. 45(3). 1451–1469. 10 indexed citations

Skike, Candice E. Van, Nicholas DeRosa, Verónica Galván, & Stacy A. Hussong. (2023). Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer’s disease. GeroScience. 45(3). 1987–1996. 13 indexed citations

Owens, Cameron D., Camila Bonin Pinto, Péter Mukli, et al.. (2023). Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study. PLoS ONE. 18(8). e0289508–e0289508. 11 indexed citations

Chocrón, E. Sandra, Erin Munkácsy, Candice E. Van Skike, et al.. (2022). Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer’s-like pathology in mouse and fly APP overexpression models. Science Advances. 8(23). eabk2252–eabk2252. 33 indexed citations

Quarleri, Jorge, M. Victoria Delpino, & Verónica Galván. (2022). Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries. GeroScience. 44(4). 2095–2103. 84 indexed citations

Quarleri, Jorge, Verónica Galván, & M. Victoria Delpino. (2022). Henipaviruses: an expanding global public health concern?. GeroScience. 44(5). 2447–2459. 24 indexed citations

Wen, Bingqiang, Vladimir Ustiyan, Guolun Wang, et al.. (2020). In Vivo Generation of Lung and Thyroid Tissues from Embryonic Stem Cells Using Blastocyst Complementation. American Journal of Respiratory and Critical Care Medicine. 203(4). 471–483. 40 indexed citations

Skike, Candice E. Van, Ai‐Ling Lin, Raquel R Burbank, et al.. (2019). mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging. Aging Cell. 19(1). e13057–e13057. 62 indexed citations

Castillo‐Carranza, Diana L., Ashley N. Nilson, Candice E. Van Skike, et al.. (2017). Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies. Aging and Disease. 8(3). 257–257. 89 indexed citations

10.

Cremers, Claudia M., Daniela Knoefler, Stephanie N. Gates, et al.. (2016). Polyphosphate: A Conserved Modifier of Amyloidogenic Processes. Molecular Cell. 63(5). 768–780. 126 indexed citations

11.

Hurez, Vincent, Vinh Dao, Aijie Liu, et al.. (2015). Chronic mTOR inhibition in mice with rapamycin alters T , B , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice. Aging Cell. 14(6). 945–956. 98 indexed citations

12.

Galván, Verónica & Matthew J. Hart. (2015). Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(5). 992–1007. 28 indexed citations

13.

Lin, Ai-Ling, Daniel Pulliam, Sathyaseelan S. Deepa, et al.. (2013). Decreased in vitro Mitochondrial Function is Associated with Enhanced Brain Metabolism, Blood Flow, and Memory in Surfl-Deficient Mice. Journal of Cerebral Blood Flow & Metabolism. 33(10). 1605–1611. 28 indexed citations

14.

Galván, Verónica, et al.. (2013). The Effects of Cell Phone Conversations on the Attention and Memory of Bystanders. PLoS ONE. 8(3). e58579–e58579. 16 indexed citations

15.

Spilman, Patricia, Natalia Podlutskaya, Matthew J. Hart, et al.. (2011). Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease. PLoS ONE. 6(12). 2 indexed citations

16.

Robinson, Renã A. S., Rukhsana Sultana, Verónica Galván, et al.. (2011). Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor proteinΞ. Neuroscience. 177. 207–222. 55 indexed citations

17.

Butterfield, D. Allan, Verónica Galván, Huidong Tang, et al.. (2009). In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP. Free Radical Biology and Medicine. 48(1). 136–144. 166 indexed citations

18.

Galván, Verónica, Junli Zhang, Olivia Gorostiza, et al.. (2008). Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behavioural Brain Research. 191(2). 246–255. 39 indexed citations

19.

Jin, Kunlin & Verónica Galván. (2007). Endogenous Neural Stem Cells in the Adult Brain. Journal of Neuroimmune Pharmacology. 2(3). 236–242. 42 indexed citations

20.

Wang, Yaoming, et al.. (2006). Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. Brain Research. 1115(1). 186–193. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact